期刊档案 · 医学-内分泌学与代谢
Pituitary
ISSN 1386-341X · eISSN 1573-7403 · Springer US · UNITED STATES · Quarterly · 创刊 1998
Pituitary 中科院 医学 2区（2025 年升级版），影响因子 3.75，混合开放获取，APC 约 4,490 美元，近 24 个月 56 篇文章投稿到接收中位 48 天，录用比例约75%（社区反馈），2025 年发文 138 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Pituitary 由 Springer US 出版，属中科院医学大类（2025 升级版2区）。按 OpenAlex 近年发文统计，该刊主要发表 Pituitary Gland Disorders and Treatments、Growth Hormone and Insulin-like Growth Factors、Adrenal and Paraganglionic Tumors 等主题的论文，这 3 个主题约占 63.3%，主导子领域为 Endocrinology, Diabetes and Metabolism。（根据 OpenAlex 主题统计与中科院分区数据生成）
Overview Pituitary publishes basic and clinical articles in all fields of neuroendocrinology on pathophysiology, diagnosis and treatment of pituitary diseases focusing on endocrine, neuroradiological, neurosurgical, pathological and radiotherapy aspects. Pituitary founded by Shlomo Melmed in 1998 is the official journal of the Pituitary Society and the Growth Hormone Research Society. Pituitary publishes articles on pathophysiological interactions of pituitary axes with metabolic signals, or non-classical endocrine systems as heart and bone. Pituitary is also devoted to developing areas of neuroendocrinology–such as the pituitary involvement in infectious diseases like COVID-19. Authors can contribute to the Journal choosing among several categories the one which best fits with their submission. The Editorial team is committed to rapid turnaround time and insightful peer review of submitted manuscripts. AIM AND SCOPES The journal considers articles in all fields of neuroendocrinology including but not limited to: Physiological regulation of pituitary hormone secretion and action; Mechanisms underlying pituitary diseases; Diagnosis and treatment of pituitary diseases; Pharmacological trials in pituitary diseases; Systemic comorbidities of pituitary diseases; Pituitary involvement in systemic diseases; Metabolic effects of pituitary hormones; Guidelines/Position Statements in pituitary diseases; Methodological advances (experimental and clinical) in pituitary disorders.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-内分泌学与代谢
主编 Andrea Giustina出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 21、意大利 17、西班牙 4、法国 2、瑞典 2（共 58 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Pituitary Gland Disorders and TreatmentsMedicine35.6%
- Growth Hormone and Insulin-like Growth FactorsMedicine18.4%
- Adrenal and Paraganglionic TumorsMedicine9.3%
- Adrenal Hormones and DisordersMedicine7.1%
- Glioma Diagnosis and TreatmentMedicine4.4%
- Meningioma and schwannoma managementMedicine4.4%
- Neuroendocrine Tumor Research AdvancesMedicine3.4%
- Head and Neck Surgical OncologyMedicine2.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 2 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 2 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbaseCASCurrent Contents出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、AGRICOLA、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 3.75LetPub ·
- 影响因子（出版商公布） 2025
- 3.8出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 3.9出版商官网 ·
- CiteScore 2026-06
- 6.4LetPub ·
- SJR 2026-06
- 1.16LetPub ·
- SNIP 2026-06
- 1.46LetPub ·
- h-index
- 57LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 1,356OpenAlex ·
- 两年平均被引
- 3.14OpenAlex ·
- 自引率
- 15.8%LetPub ·
- Gold OA 文章占比
- 41.61%LetPub ·
发文规模
- 年文章数
- 116LetPub ·
- 年下载量（出版商公布） 2025
- 538,800出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 2,082 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 136 | 66 | 78 |
| 2025 | 138 | 84 | 435 |
| 2024 | 111 | 61 | 695 |
| 2023 | 76 | 29 | 972 |
| 2022 | 98 | 40 | 1,658 |
| 2021 | 83 | 46 | 1,799 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
48 天投稿到接收中位数 · P25–P75 32 天 – 73 天
- 接收到上线
- 中位数 20 天（97 篇）
- 投稿到上线
- 中位数 72 天
- 样本
- 56 篇有投稿与接收日期的文章（窗口内共 296 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 平均6月LetPub ·
- 平均录用比例（社区反馈）
- 75%LetPub ·
- 投稿到首次决定
- 1 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,490 / EUR 3,790 / GBP 2,990 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
征稿中的专刊1 个，按截稿日期
出版商官网投稿准备要点3 项，摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 正文篇幅
- ≤ 3,500 词
接收的文章类型14 种，含篇幅限制
- brief reportcs, or that present a proof of concept. Brief reports should be presented in a very concise way (limit of 1200 words (excluding abstract, references, and table/…正文 ≤ 1,200 词 · 参考文献 ≤ 30
- editorialPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …正文 ≤ 3,500 词 · 参考文献 ≤ 30
- forumThese contributions no longer than 1000 words could be solicited by the Editor-in-Chief or proposed by the partner Society (eicpituitary@gmail.com).正文 ≤ 1,000 词
- guidelinesThis type of article should not exceed 3000 words and 250 references.正文 ≤ 3,000 词 · 参考文献 ≤ 250
- innovationThis type of article has a word limit of 2000 and no more than 100 references with at least 1 Figure or 1 Table.正文 ≤ 2,000 词 · 参考文献 ≤ 100
- letter to the editorText is limited to 700 words, with no abstract. There may be 1 figure or 1 Table, up to 3 references, and no more than 3 authors, with author affiliations only …正文 ≤ 700 词 · 参考文献 ≤ 3
- letters to the editorPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …未说明篇幅
- meta-analysisPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …正文 ≤ 3,000 词 · 参考文献 ≤ 100
- methodologyThis type of article has a word limit of 1500, 1 figure or table and no more than 30 references.正文 ≤ 1,500 词 · 参考文献 ≤ 30
- mini-reviewThis type of article has a word limit of 2000 and no more than 100 references with at least 1 Figure or 1 Table.正文 ≤ 2,000 词 · 参考文献 ≤ 100
- perspectiveThis type of article has a word limit of 1500, 1 figure or table and no more than 30 references with 1 Figure or 1 Table.正文 ≤ 1,500 词 · 参考文献 ≤ 30
- regular articlePituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …未说明篇幅
- research articleManuscripts should not exceed 4,000 words, 60 references, and maximum 5 tables/figures.正文 ≤ 4,000 词 · 参考文献 ≤ 60
- reviewPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …正文 ≤ 3,500 词 · 参考文献 ≤ 200
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
原文 ↗出版商官网 ·- 数据可用性 Data availability statements
Data transparency 模型摘要
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
原文 ↗出版商官网 ·- 出版伦理 Compliance with Ethical Standards
Retrospective ethics approval 模型摘要
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
To find out more about publishing your work Open Access in Pituitary, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审
Suggesting / excluding reviewers 模型摘要
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer US
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- Quarterly
- 创刊年份
- 1998
- ISSN
- 1386-341X
- 电子版 ISSN
- 1573-7403
- 学会 / 主办单位
- Pituitary Society and the Growth Hormone Research Society
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Pituitary 的常见问题
Pituitary 是中科院几区期刊？
2025 年升级版分区表中，Pituitary 为医学 2区，小类 内分泌学与代谢 2 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Pituitary 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 3.75，CiteScore 为 6.4，h-index 为 100。
Pituitary 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）56 篇已发表文章登记的日期，投稿到接收的中位数为 48 天（四分位 32–73 天）；投稿社区反馈的平均审稿速度为约 6 个月，平均录用比例反馈为“约75%”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Pituitary 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；关键词：≥ 4 个；正文篇幅：≤ 3,500 词。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Pituitary 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 58 位编委中，没有中国大陆学者；人数最多的国家是 美国（21 位）、意大利（17 位）、西班牙（4 位）。统计按编委会页面列出的机构国家计，仅供参考。
Pituitary 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Pituitary 被 SCIE、Scopus 收录。期刊官网自述还被 MEDLINE、Embase、CAS、Current Contents 收录，该清单未与各数据库逐一核对。
Pituitary 是开放获取期刊吗？版面费多少？
Pituitary 为混合开放获取。选择开放获取发表时APC 约 4,490 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。